Navigation Links
Antifungal Drug May Help Ease Asthma
Date:12/29/2008

People sensitive to fungi may benefit from itraconazole, study finds

MONDAY, Dec. 29 (HealthDay News) -- An antifungal drug may offer hope for severe asthma patients who also suffer from a sensitivity to certain fungi, a new British study says.

A twice-daily dose of itraconazole improved runny nose, morning lung function and the quality of life of 62 percent of people with severe asthma and allergic sensitivity to at least one of seven different common fungi in the double-blind study conducted by The University of Manchester.

However, the remaining patients who took the drug dropped out of the 32-week trial before its completion. Some cited side effects such as nausea, breathlessness and muscle weakness.

The findings appear in the first January issue of the American Journal of Respiratory and Critical Care Medicine.

"This study indicates that fungal allergy is important in some patients with severe asthma, and that oral antifungal therapy is worth trying in difficult-to-treat patients. Clearly itraconazole will not suit everyone and is not always helpful, but when it is the effect is dramatic," lead investigator David Denning, a professor of medicine and medical mycology at The University of Manchester, said in a news release issued by the journal's publisher. "These findings open the door to a new means of helping patients with severe asthma, and raise intriguing questions related to fungal allergy and asthma."

More information

The National Library of Medicine has more about asthma.



-- Kevin McKeever



SOURCE: American Thoracic Society, news release, Dec. 29, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients
2. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
3. Echinocandins Show Growth Among All Antifungal Classes
4. Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
5. Genetic predisposition increases childhood asthma risk
6. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
7. New Asthma Guidelines Stress Disease Control
8. Study finds some kids are being misdiagnosed with asthma
9. Childhood asthma still inappropriately treated in the UK
10. Parents perceptions can hamper kids asthma care, study finds
11. Clean to Ease Allergy and Asthma Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antifungal Drug May Help Ease Asthma 
(Date:5/2/2016)... NV (PRWEB) , ... May 02, 2016 , ... ... Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award that will ... based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction ...
(Date:5/2/2016)... ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed roster was ... made the cut. The WUGC is being held in London, England this year from June ... the men’s division, another gold in the women’s masters division, and a silver in the ...
(Date:5/2/2016)... ... , ... Pregnancy Awareness Month offers a great time to get familiar with ... are ready to have a baby, it’s best to get started before age becomes ... Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant to ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... division of Permobil, recently completed two groundbreaking studies that determined that the adjustability ... – are critical in the prevention of pressure injuries, which are now referred ...
(Date:5/2/2016)... Washington, DC (PRWEB) , ... May 02, 2016 , ... ... “ How CMS’s Medicare Part B Payment Model Could Transform the Pharma Landscape .” ... an eye on reducing its spend on provider-administered drugs while preserving care provided to ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:4/29/2016)... 2016 Glycotope GmbH, a clinical-stage ... the appointment of Dr. Alfredo Zurlo as ... oncologist with many years clinical experience and a proven ... last role was at Mologen AG where he was ... Previously Dr. Zurlo held various positions at F Hoffmann ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
Breaking Medicine Technology: